| Pharmaceutical active ingredients: |
| Zidovudine |
| Available forms, composition and doses of Retrovir AZT: |
| Capsules; Oral; Zidovudine 100 mgCapsules; Oral; Zidovudine 250 mgInjectable; Injection; Zidovudine 10 mg / mlSolution; Oral; Zidovudine 50 mg / 5 mlSyrup; Oral; Zidovudine 50 mg / 5 mlTablets, Film-Coated; Oral; Zidovudine 300 mgTablets; Oral; Zidovudine 300 mg |
| Retrovir AZT medical category: |
| Human:AntiviralsNucleoside and nucleotide reverse transcriptase inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J05AF01 - Zidovudine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKlineViiV Healthcare |
| Related documents and information about Retrovir AZT: |
| Retrovir prescribing information (PDF)Retrovir injection prescribing information (PDF) |